功能对移植不合格多发性骨髓瘤患者初始治疗的影响
Yutaka Shimazu1,2, Junya Kanda3, Teruhito Takakuwa4
1Department of Hematology, Graduate School of Medicine, Kyoto University, 54, Kawaramachi, Shogoin, Sakyoku, Kyoto, 606-8507, Japan. yshimazu@kuhp.kyoto-u.ac.jp.
Annals of hematology
|August 21, 2024
概括
对于患有多发性骨髓瘤的功能障碍患者来说,治疗选择至关重要. 与RVd/D-Rd相比,像D-VMP/D-Vd这样的疗法可能提供更好的生存结果,特别是在功能受损的患者中.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 多发性骨髓瘤 (MM) 的预后有所改善,但功能障碍 (RI) 会使治疗复杂化,并使治疗结果恶化.
- 由于缺乏确定的标准,对不符合移植条件的MM患者的RI最佳初始治疗仍然不清楚.
研究的目的:
- 调查功能障碍 (RI) 对接受初始治疗的移植不合格多发性骨髓瘤 (MM) 患者的整体存活率 (OS) 的影响.
- 为了比较MM患者不同程度的功能不同治疗方案的有效性.
主要方法:
- 对349名有症状的MM患者 (年龄≥65,适合,移植不合格) 的回顾性分析.
- 分析的数据包括年龄,治疗方案 (RVd,D-VMP,D-Rd,D-Vd),国际分期系统 (ISS) 阶段,型,性能状态和估计的淋巴细胞过率 (eGFR <50 vs. ≥50 ml/min/1.73m2).
- 总体存活率 (OS) 根据这些因素和特定治疗方案进行评估.
主要成果:
- 多变量分析显示,ISS III阶段 (p=0.029) 和eGFR <50 (p<0.001) 的患者的生存寿命较短.
- 在EGFR<50.0的患者中,RVd/D-Rd疗程的OS显著较短.
- 在D-VMP/D-Vd疗法下的OS在EGFR<50和EGFR≥50.0的患者之间没有显著差异.
结论:
- 移植不合格的MM患者具有先进的ISS阶段和RI的预后不佳.
- 使用D-VMP或D-Vd方案的初始治疗可能不会受到功能障碍的影响,这表明这种患者群体的治疗选择可能更有利.
相关概念视频
Renal Failure: Dose Adjustments
71
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
71
Factors Affecting Renal Clearance: Renal Impairment
63
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
63
Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317


